A transgenic rat model of PD was used to study the effects of human mesenchymal stem cell (hMSC) conditioned medium
Bad News GLP-1 drugs were associated with increased risks of gastrointestinal disorders and a lot of other things that make sense like nausea and vomiting, headaches, sleep disturbances, hypotension (low blood pressure) and syncope (passing out)
Users in the Netherlands may contact the Autoriteit Persoonsgegevens (AP) at www.autoriteitpersoonsgegevens.nl
EMA and the Heads of Medicines Agencies (HMA), through the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), have issued recommendations to tackle shortages of the glucagon-like peptide-1 (GLP-1) receptor agonists Ozempic (semaglutide), Saxenda (liraglutide), Trulicity (dulaglutide) and Victoza (liraglutide)
Afshary K, Chamanara M, Talari B, Rezaei P, Nassireslami E
Y., and Shang, P